Children continue to be underrepresented in drug trials

Children continue to be underrepresented in drug trials
Even for conditions with a high pediatric disease burden, only a small proportion of clinical drug trials study pediatric patients, according to research published online July 23 in Pediatrics.

(HealthDay) -- Even for conditions with a high pediatric disease burden, only a small proportion of clinical drug trials study pediatric patients, according to research published online July 23 in Pediatrics.

Florence T. Bourgeois, M.D., M.P.H., from Harvard University in Boston, and colleagues identified all registered in ClinicalTrials.gov with start dates between 2006 and 2011 and tracked the resulting publications for conditions with a high burden of pediatric disease.

The researchers found that, for the selected conditions, 59.9 percent of the disease burden was seen in children, but only 292 of 2,440 trials (12.0 percent) were for (P < 0.001). Trials conducted without industry funding were significantly more common in pediatric populations compared with adults (58.6 versus 35.0 percent). Pediatric randomized trials were significantly less likely to examine safety outcomes compared with adult randomized trials (10.1 versus 16.9 percent) and had a modestly higher probability of publication in the examined time frame (32.8 versus 23.2 percent; P = 0.04).

"There is substantial between pediatric burden of disease and the amount of clinical trial research devoted to pediatric populations," the authors write. "This may be related in part to trial funding, with relying primarily on government and nonprofit organizations."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Children neglected in clinical drug trials

Apr 29, 2012

Although children are more likely than adults to suffer from many diseases, few clinical trials are being conducted to test drugs in pediatric patients, according to a study to be presented Saturday, April 28, at the Pediatric ...

Positive outcome no more likely in industry-funded trials

Jul 05, 2012

(HealthDay) -- Industry-sponsored clinical trials of rheumatoid arthritis drugs are no more likely to report positive outcomes than trials funded by other means, and in many cases use better methodology, according ...

Recommended for you

HPV vaccine knowledge doesn't predict vaccination

Sep 16, 2014

(HealthDay)—Neither parents' nor adolescents' knowledge about human papillomavirus (HPV) vaccines predicts vaccination compliance, according to a study published online Sept. 15 in Pediatrics.

User comments